356 related articles for article (PubMed ID: 22724017)
1. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
Laitinen EM; Tommiska J; Sane T; Vaaralahti K; Toppari J; Raivio T
PLoS One; 2012; 7(6):e39450. PubMed ID: 22724017
[TBL] [Abstract][Full Text] [Related]
2. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
Tommiska J; Känsäkoski J; Christiansen P; Jørgensen N; Lawaetz JG; Juul A; Raivio T
Eur J Med Genet; 2014 Jul; 57(7):345-8. PubMed ID: 24732674
[TBL] [Abstract][Full Text] [Related]
3. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
Brioude F; Bouvattier CE; Lombès M
Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
[TBL] [Abstract][Full Text] [Related]
4. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland.
Laitinen EM; Vaaralahti K; Tommiska J; Eklund E; Tervaniemi M; Valanne L; Raivio T
Orphanet J Rare Dis; 2011 Jun; 6():41. PubMed ID: 21682876
[TBL] [Abstract][Full Text] [Related]
5. Novel FGFR1 and KISS1R Mutations in Chinese Kallmann Syndrome Males with Cleft Lip/Palate.
Xu H; Niu Y; Wang T; Liu S; Xu H; Wang S; Liu J; Ye Z
Biomed Res Int; 2015; 2015():649698. PubMed ID: 26199944
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism.
Aoyama K; Mizuno H; Tanaka T; Togawa T; Negishi Y; Ohashi K; Hori I; Izawa M; Hamajima T; Saitoh S
J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1111-1118. PubMed ID: 28915117
[TBL] [Abstract][Full Text] [Related]
7. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
Quaynor SD; Kim HG; Cappello EM; Williams T; Chorich LP; Bick DP; Sherins RJ; Layman LC
Fertil Steril; 2011 Dec; 96(6):1424-1430.e6. PubMed ID: 22035731
[TBL] [Abstract][Full Text] [Related]
9. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and molecular aspects of congenital isolated hypogonadotropic hypogonadism].
Tusset C; Trarbach EB; Silveira LF; Beneduzzi D; Montenegro L; Latronico AC
Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):501-11. PubMed ID: 22218430
[TBL] [Abstract][Full Text] [Related]
11. Genetics of Hypogonadotropic Hypogonadism.
Topaloglu AK; Kotan LD
Endocr Dev; 2016; 29():36-49. PubMed ID: 26680571
[TBL] [Abstract][Full Text] [Related]
12. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Kim HG; Kurth I; Lan F; Meliciani I; Wenzel W; Eom SH; Kang GB; Rosenberger G; Tekin M; Ozata M; Bick DP; Sherins RJ; Walker SL; Shi Y; Gusella JF; Layman LC
Am J Hum Genet; 2008 Oct; 83(4):511-9. PubMed ID: 18834967
[TBL] [Abstract][Full Text] [Related]
13. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
Känsäkoski J; Fagerholm R; Laitinen EM; Vaaralahti K; Hackman P; Pitteloud N; Raivio T; Tommiska J
Pediatr Res; 2014 May; 75(5):641-4. PubMed ID: 24522099
[TBL] [Abstract][Full Text] [Related]
14. [GnRH deficiency: new insights from genetics].
Kottler ML; Hamel A; Malville E; Richard N
J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of pathogenic variants and digenic disease in patients diagnosed with normosmic hypogonadotropic hypogonadism/Kallmann Syndrome.
Poch A; Dougherty MP; Roman RA; Chorich L; Hawkins Z; Kim SH; Kim HG; Layman LC
Mol Cell Endocrinol; 2024 Aug; 589():112224. PubMed ID: 38593951
[TBL] [Abstract][Full Text] [Related]
16. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.
Costa-Barbosa FA; Balasubramanian R; Keefe KW; Shaw ND; Al-Tassan N; Plummer L; Dwyer AA; Buck CL; Choi JH; Seminara SB; Quinton R; Monies D; Meyer B; Hall JE; Pitteloud N; Crowley WF
J Clin Endocrinol Metab; 2013 May; 98(5):E943-53. PubMed ID: 23533228
[TBL] [Abstract][Full Text] [Related]
17. CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.
Jongmans MC; van Ravenswaaij-Arts CM; Pitteloud N; Ogata T; Sato N; Claahsen-van der Grinten HL; van der Donk K; Seminara S; Bergman JE; Brunner HG; Crowley WF; Hoefsloot LH
Clin Genet; 2009 Jan; 75(1):65-71. PubMed ID: 19021638
[TBL] [Abstract][Full Text] [Related]
18. Molecular defects of the GnRH-receptor gene in Chinese patients with idiopathic hypogonadotropic hypogonadism and the severity of hypogonadism.
Fathi AK; Hu S; Fu X; Huang S; Liang Y; Ning Q; Luo X
J Pediatr Endocrinol Metab; 2012; 25(7-8):659-68. PubMed ID: 23155690
[TBL] [Abstract][Full Text] [Related]
19. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
